Extracorporeal Photopheresis by Hildegard T Greinix

Extracorporeal Photopheresis by Hildegard T Greinix

Regular price
Checking stock...
Regular price
Checking stock...
Summary

Extracorporeal photopheresis (ECP) is the first FDA approved cellular photoimmunotherapy for cancer and has demonstrated efficacy in T-cell mediated disorders including prevention and treatment of acute and chronic graft-versus-host disease, organ transplant rejection, scleroderma, Crohn’s disease and diabetes mellitus.

The feel-good place to buy books
  • Free US shipping over $15
  • Buying preloved emits 41% less CO2 than new
  • Millions of affordable books
  • Give your books a new home - sell them back to us!

Extracorporeal Photopheresis by Hildegard T Greinix

Extracorporeal photopheresis (ECP) is the first FDA approved cellular photoimmunotherapy for cancer and has demonstrated efficacy in T-cell mediated disorders including prevention and treatment of acute and chronic graft-versus-host disease, organ transplant rejection, scleroderma, Crohn's disease and diabetes mellitus. Due to its exceptional safety profile ECP has gained wide international acceptance through the efforts of leading clinical investigators. Exciting preclinical data and clinical observations provide insight into the mechanisms of action of ECP and are the basis for further clinical investigations.

Univ. Prof. Dr. Hildegard T. Greinix, Prof. Dr. Robert Knobler, both Medical University of Vienna Departments of Internal Medicine I and Dermatology Vienna, Austria.

SKU Unavailable
ISBN 13 9783110275940
ISBN 10 3110275945
Title Extracorporeal Photopheresis
Author Hildegard T Greinix
Condition Unavailable
Binding Type Hardback
Publisher De Gruyter
Year published 2012-09-14
Number of pages 227
Cover note Book picture is for illustrative purposes only, actual binding, cover or edition may vary.